Kerry Blanchard, Everest CEO
Trans-Pacific power player Everest jumps on mRNA vaccine deal with Providence, paying $100M upfront to tap platform play
Everest is jumping aboard the Covid-19 mRNA vaccine train.
While China has used other vaccine technologies to vaccinate its population, companies are starting to explore …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.